Kenya to roll out lenacapavir HIV prevention injection by 2026 in landmark move

he injectable drug, approved by the US Food and Drug Administration successful June 2025 and added to updated World Health Organisatio guidelines successful July 2025, volition complement existing pre-exposure prophylaxis (PrEP) methods.